EV71 vaccine

Pipeline

Status by Indication[3][1]

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity5 trials

Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children

Completed·MMedigen Vaccine Biologics Corp.··NCT04072276·227 enrolled

A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects

Completed·EEnimmune Corporation·Phase 2·NCT03268083·140 enrolled

A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old

Completed·EEnimmune Corporation·Phase 2·NCT02777411·122 enrolled

Show 2 more trials

Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine

Completed·Sinovac Biotech Co., Ltd·Phase 4·NCT03278132·120 enrolled

A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine

Completed·NNational Health Research Institutes, Taiwan·Phase 1·NCT01268787·60 enrolled

Enterovirus3 trials

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

Recruiting·IInstitute of Medical Biology, Chinese Academy of Medical Sciences·Phase 4·NCT06146088·1,500 enrolled

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Completed·Sinovac Biotech Co., Ltd··NCT02001233·10,077 enrolled

The Phase IVd of Inactivated Enterovirus 71 Vaccine

Unknown status·CChinese Academy of Medical Sciences·Phase 4·NCT03296410·1,220 enrolled

Efficacy1 trial

Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71

Completed·JJiangsu Province Centers for Disease Control and Prevention·Phase 4·NCT03582761·40,000 enrolled

Clinical Trial1 trial

Clinical Trial for Batch Consistency of EV71 Vaccine

Completed·Sinovac Biotech Co., Ltd·Phase 4·NCT07026500·720 enrolled

Influenza1 trial

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

Completed·CChina National Biotec Group Company Limited·Phase 4·NCT04091880·1,134 enrolled

2 more indications

Enterovirus Infections1 trial

A Phase III, Multiple-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity, and Safety of an Adjuvanted, Inactivated Enterovirus 71 (EV71) Vaccine in Healthy Infants and Children

Completed·EEnimmune Corporation·Phase 3·NCT05099029·3,982 enrolled

Hand, Foot, and Mouth Disease (HFMD)1 trial

Immunogenicity and Safety of Enterovirus Type 71 Vaccine, Inactivated in Healthy Children Aged 6~71 Months: A Single-armed Bridging Clinical Trial

Not yet recruiting·Sinovac Biotech Co., Ltd·Preclinical·NCT07793175·320 enrolled

Details

Drug Info

Related News